Opportunities for Enhanced Public Health Surveillance via Molecular Detection and Sequencing of Diverse Respiratory Viruses From Self-collected SARS-CoV-2 Antigen Test Swabs
Kat Schmidt(Henry M. Jackson Foundation), Rhonda E Colombo(Henry M. Jackson Foundation), Timothy Burgess(Uniformed Services University of the Health Sciences), Stephanie A Richard(Henry M. Jackson Foundation), Anthony C Fries(Wright-Patterson Air Force Base), Drake H. Tilley(United States Naval Medical Research Unit SOUTH), Kamala Thapa(Henry M. Jackson Foundation), Mark P. Simons(Uniformed Services University of the Health Sciences), R Tant, Robert J. O’Connell(Walter Reed Army Institute of Research), Emily Hone(Uniformed Services University of the Health Sciences), L Ulomi(Henry M. Jackson Foundation), Julian Davies(Eli Lilly (United States)), Simon Pollett(Henry M. Jackson Foundation), Amber Michel(Henry M. Jackson Foundation), M. Wayman, Jennifer Rothenberg, Vivian Hogan(Henry M. Jackson Foundation), Chantele Friend(Henry M. Jackson Foundation)
Cited by 2
Related Papers
The Frequency of Autoimmune N-Methyl-D-Aspartate Receptor Encephalitis Surpasses That of Individual Viral Etiologies in Young Individuals Enrolled in the California Encephalitis Project
|Clinical Infectious Diseases|2012|732
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
|Science Translational Medicine|2021|503
Cohort Study of Molecular Identification and Typing of <i>Mycobacterium abscessus, Mycobacterium massiliense</i> , and <i>Mycobacterium bolletii</i>
|Journal of Clinical Microbiology|2009|221
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection
|bioRxiv (Cold Spring Harbor Laboratory)|2020|175
Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study
|The Lancet Respiratory Medicine|2017|118